Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 10/20 | 0.47 |
| ▸ | GPR183 | P32249 | 3/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PYGL | P06737 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2899274 | 0.93 | CCR2 (0.47) | CCR2GPR183SLC2A1NPC1RAB9A | |
| SCHEMBL2902728 | 0.93 | CCR2 (0.47) | CCR2GPR183SLC2A1NPC1RAB9A | |
| SCHEMBL2899434 | 0.92 | CCR2 (0.47) | CCR2GPR183SLC2A1NPC1RAB9A | |
| SCHEMBL2899436 | 0.92 | CCR2 (0.47) | CCR2GPR183SLC2A1NPC1RAB9A | |
| SCHEMBL2903082 | 0.92 | CCR2 (0.47) | CCR2GPR183SLC2A1NPC1RAB9A | |
| SCHEMBL2902212 | 0.92 | CCR2 (0.49) | CCR2GPR183SLC2A1NPC1RAB9A | |
| SCHEMBL2902209 | 0.92 | CCR2 (0.49) | CCR2GPR183SLC2A1NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL2902448 | 0.91 | CCR2 (0.49) | CCR2GPR183SLC2A1NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL2899348 | 0.91 | CCR2 (0.49) | CCR2GPR183SLC2A1NPC1RAB9A | |
| SCHEMBL2899444 | 0.91 | CCR2 (0.45) | CCR2GPR183SLC2A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2010506-B1 | DIAZEPAN DERIVATIVES MODULATORS OF CHEMOKINE RECEPTORS | HOFFMANN LA ROCHE (CH) | 2010-08-04 | — | — | EP | disclosed |